Literature DB >> 8857125

Reversible hepatic cytolysis during almitrine bismesylate treatment for posttraumatic ARDS.

J C Sicsic, E Jugan, P Moine, A Edouard, K Samii.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8857125     DOI: 10.1007/bf01720725

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  5 in total

1.  Almitrine effect on nitric oxide inhalation in adult respiratory distress syndrome.

Authors:  D M Payen; C Gatecel; P Plaisance
Journal:  Lancet       Date:  1993-06-26       Impact factor: 79.321

2.  Effects and handling of almitrine bismesylate in healthy subjects.

Authors:  C N MacLeod; R W Thomas; E A Bartley; G W Parkhurst; R T Bachand
Journal:  Eur J Respir Dis Suppl       Date:  1983

3.  Relationships between age-dependent changes in the effect of almitrine on H(+)-ATPase/ATPsynthase and the pattern of membrane fatty acid composition.

Authors:  M Jumelle-Laclau; M Rigoulet; N Averet; X Leverve; L Dubourg; A Carbonneau; M Clerc; B Guerin
Journal:  Biochim Biophys Acta       Date:  1993-02-08

4.  Additive effect on gas exchange of inhaled nitric oxide and intravenous almitrine bismesylate in the adult respiratory distress syndrome.

Authors:  M Wysocki; C Delclaux; E Roupie; O Langeron; N Liu; B Herman; F Lemaire; L Brochard
Journal:  Intensive Care Med       Date:  1994       Impact factor: 17.440

5.  Sequential treatment with low dose almitrine bismesylate in hypoxaemic chronic obstructive airways disease.

Authors:  P A Bardsley; P Howard; O Tang; D Empey; B Harrison; M D Peake; J O'Reilly; J F Riordan; J Wilkinson; F Arnaud
Journal:  Eur Respir J       Date:  1992-10       Impact factor: 16.671

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.